Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCRL | Q16602 | 14/20 | 0.39 |
| ▸ | CALCB | P10092 | 1/20 | 0.34 |
| ▸ | ADM2 | Q7Z4H4 | 1/20 | 0.34 |
| ▸ | RAMP1 | O60894 | 5/20 | 0.32 |
| ▸ | CALCA | P06881 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1896085 | 0.82 | CALCRL (0.46) | CALCRLRAMP1 | |
| SCHEMBL1898117 | 0.77 | CALCRL (0.45) | CALCRLCALCBADM2RAMP1 | |
| SCHEMBL1894821 | 0.70 | CALCRL (0.43) | CALCRLMAPK1 | |
| SCHEMBL1894819 | 0.70 | CALCRL (0.43) | CALCRLMAPK1 | |
| SCHEMBL2212667 | 0.67 | CALCRL (0.43) | CALCRLMAPK1 | |
| SCHEMBL3483312 | 0.65 | CALCRL (0.37) | CALCRLCALCBADM2RAMP1CALCA | |
| SCHEMBL2213111 | 0.65 | CALCRL (0.55) | CALCRL | |
| SCHEMBL16502185 | 0.64 | CALCRL (0.43) | CALCRLRAMP1 | |
| SCHEMBL13987045 | 0.64 | CALCRL (0.57) | CALCRLMAPK1 | |
| SCHEMBL13791578 | 0.64 | CALCRL (0.60) | CALCRLRAMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2091533-B1 | CONSTRAINED SPIROCYCLIC COMPOUNDS AS CGRP RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME (US) | 2012-11-28 | — | — | EP | disclosed |
| US-7951795-B2 | Constrained spirocyclic compounds as CGRP receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2011-05-31 | — | — | US | disclosed |
| US-20100069359-A1 | CONSTRAINED SPIROCYCLIC COMPOUNDS AS CGRP RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME LLC | 2010-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069359-A1 | CONSTRAINED SPIROCYCLIC COMPOUNDS AS CGRP RECEPTOR ANTAGONISTS | CALCRL, BDKRB1, CALCR | CALCRL 1/4885CALCB 9/4885ADM2 140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.